We previously reported that febuxostat effectively suppresses RANKL-induced ROS production and osteoclastogenesis and that oral febuxostat administration alleviates bone loss in ovariectomized mice as an osteoporosis model. The gene discussed is TNFSF11; the disease is osteoporosis.